Natco Pharma Ltd Share Price

Overview

Natco Pharma Ltd share price is currently ₹869.13, up by ₹3.53 (0.41%) from its previous closing price of ₹865.60. The share price has declined -4.64% over the past month and gained 0.73% over the past year. The stock's 52-week low and high are ₹776.83 and ₹1,209.98, respectively. Natco Pharma Ltd has a market capitalisation of ₹ 15,800.00 Cr. The share price was last updated on 24 Aug 2026, 02:45 PM IST.

Natco Pharma Ltd

NATCOPHARM

₹0.00

₹3.53

0.41%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 02:45:54 pm IST

Market Data

Open Price

₹879.10

Prev. Close

₹865.60

₹867.84

Day Low

₹879.10

Day High

₹776.83

52 Week Low

₹1,209.98

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

13.60

Sector PE

42.03

PB Ratio

2.05

Sector PB

5.83

EPS

63.93

Dividend Yield

0.75

Today's Volume

251.902 K

5 Day Avg. Volume

297.451 K

PEG Ratio

0.38

Market Cap.

₹ 15,800.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsInterim Dividend of 75% at ₹1.5/Share	20-Aug-2026	20-Aug-2026
DividendsInterim Dividend of 75% at ₹1.5/Share	18-Feb-2026	18-Feb-2026
DividendsInterim Dividend of 75% at ₹1.5/Share	20-Nov-2025	20-Nov-2025
DividendsInterim Dividend of 100% at ₹2/Share	19-Aug-2025	19-Aug-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Tata Value Fund - Growth	8.25 Lac	8.25 Lac no change
Sundaram Small Cap Fund - Growth	6.16 Lac	6.16 Lac no change
Tata Small Cap Fund - Regular Plan - Growth	5.49 Lac	5.49 Lac no change
Bandhan Multi Cap Fund - Regular Plan - Growth	2.00 Lac	2.50 Lac (25%)
Nippon India Nifty Smallcap 250 Index Fund - Regular Plan - Growth	1.39 Lac	1.41 Lac (1.73%)

Show all holdings

About Natco Pharma Ltd 👋

Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with a focus on research and development. It develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. Its segments include Pharmaceuticals and Agro chemicals. The Pharmaceuticals segment is engaged in the manufacturing and selling of bulk drugs, finished dosage formulations. The Agro Chemicals segment focuses on the manufacturing and selling of agro chemicals. It is also engaged in developing, manufacturing and marketing finished dosage formulations (FDF), active pharmaceutical ingredients (APIs) and intermediates. Its product portfolio consists of two categories of agrochemicals - pesticides and bioproducts. The key focus area is to fill the gaps in the portfolio through crop phenology analysis. It has manufacturing facilities in India which cater to both domestic and international markets.